تمامی مطالب مطابق قوانین جمهوری اسلامی ایران میباشد.درصورت مغایرت از گزارش پست استفاده کنید.

جستجو

کانال خرید و فروش پرنده

پیغام سیستم

    نتيجه اي براي جستجوي شما پيدا نشد.

Ruxolitinib - Wikipedia

https://en.wikipedia.org/wiki/Ruxolitinib
Ruxolitinib is a drug for the treatment of intermediate or high-risk myelofibrosis, a
type of myeloproliferative disorder that affects the bone marrow, and for
polycythemia vera (PCV) when there has been an inadequate response to or
intolerance of hydroxyurea. Contents. [hide]. 1 Mechanism of action; 2 Side
effects  ...


Jakafi.com: Polycythemia Vera & Myelofibrosis Treatment

http://www.jakafi.com/
Low blood counts: Jakafi® (ruxolitinib) may cause your platelet, red blood cell, or
white blood cell counts to be lowered. If you develop bleeding, stop taking Jakafi
and call your healthcare provider. Your healthcare provider will perform blood
tests to check your blood counts before you start Jakafi and regularly during your
  ...


Jakafi (Ruxolitinib): Side Effects, Interactions, Warning, Dosage & Uses

https://www.rxlist.com/jakafi-drug.htm
Jakafi (ruxolitinib) Tablets are for oral administration. Each tablet contains
ruxolitinib phosphate equivalent to 5 mg, 10 mg, 15 mg, 20 mg and 25 mg of
ruxolitinib free base together with microcrystalline cellulose, lactose monohydrate
, magnesium stearate, colloidal silicon dioxide, sodium starch glycolate,
povidone and  ...


Ruxolitinib Oral : Uses, Side Effects, Interactions, Pictures, Warnings ...

https://www.webmd.com/drugs/2/drug.../ruxolitinib-oral/details
 ...

Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in ...

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627327/
Ruxolitinib became the first US Food and Drug Administration approved therapy
for myelofibrosis in 2011 and EU approval is anticipated in summer 2012. Two
large phase III trials (known as the COMFORT studies) were the basis for this
approval and were published recently. In this review article we discuss the
challenges  ...


Ruxolitinib - LiverTox - NIH

https://livertox.nih.gov/Ruxolitinib.htm
 ...

Ruxolitinib - DrugBank

https://www.drugbank.ca/drugs/DB08877
May 13, 2013  ...

Jakafi (ruxolitinib) dosing, indications, interactions, adverse effects ...

http://reference.medscape.com/drug/jakafi-ruxolitinib-999703
 ...

[PDF] 

JAKAFI (Ruxolitinib) Label - FDA

https://www.accessdata.fda.gov/drugsatfda_docs/.../202192lbl.pdf
HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include
all the information needed to use JAKAFI safely and effectively. See full
prescribing information for JAKAFI. JAKAFI™ (ruxolitinib) tablets, for oral use.
Initial U.S. Approval: 2011  ...


آمار امروز

  • تعداد وبلاگ :55617
  • تعداد مطالب :211818
  • بازدید امروز :20715
  • بازدید داخلی :2025
  • کاربران حاضر :52
  • رباتهای جستجوگر:164
  • همه حاضرین :216

آخرین کلمات جستجو شده

تگ های برتر امروز

تگ های برتر